# A Research Study to Look at How Faster Aspart Works in Chinese People With Type 1 Diabetes or Type 2 Diabetes

> **NCT04698018** · PHASE1 · COMPLETED · sponsor: **Novo Nordisk A/S** · enrollment: 23 (actual)

## Conditions studied

- Diabetes Mellitus, Type 1
- Diabetes Mellitus, Type 2

## Interventions

- **DRUG:** Faster Aspart
- **DRUG:** Novo Rapid

## Key facts

- **NCT ID:** NCT04698018
- **Lead sponsor:** Novo Nordisk A/S
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-04-20
- **Primary completion:** 2022-07-20
- **Final completion:** 2022-07-22
- **Target enrollment:** 23 (ACTUAL)
- **Last updated:** 2025-12-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04698018

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04698018, "A Research Study to Look at How Faster Aspart Works in Chinese People With Type 1 Diabetes or Type 2 Diabetes". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT04698018. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*